This trial investigated whether sleep duration is associated with cardiovascular events.

The authors evaluated the effectiveness of two different drug combinations in reducing cardiovascular events in patients with hypertension and coronary artery disease.

This study investigated if intensive blood pressure control affected self-reported patient outcomes.

They found that patients undergoing intensive control reported similar levels of quality of life and treatment satisfaction as patients undergoing a standard control regimen.

This study examined the effect of warfarin and aspirin on hemorrhagic stroke risk.

This study evaluated the association between high blood pressure (hypertension), diabetes mellitus, and C-reactive protein (a marker for inflammation) and coronary artery spasm.

This study examined the benefits of the DASH diet on the risk of cardiovascular disease (heart and blood vessel disease) in patients with hypertension. The authors found no benefit of the DASH over standard recommendations in reducing cardiovascular risk.

This study aimed to see whether statins (cholesterol-lowering drugs such as rosuvastatin [Crestor]) have a beneficial effect on blood flow to the heart.

The aim of this study was to evaluate the risk of developing open-angle glaucoma in patients with hypertension. The authors concluded that patients with hypertension are more like to develop open-angle glaucoma than those without hypertension. 

This study examined the effect of treatment on blood pressure and heart tissue changes in patients with primary aldosteronism.

This study looked at the risks and benefits associated with exercise for patients with hypertension. The authors concluded that the benefits of regular physical activity outweigh the risks and should be recommended for most patients with hypertension.